2026年11月2日星期一
M
환우통감
글로벌 속보
Yen bond offerings hit record $16bn as AI funding race reaches Japan— 日经 Nikkei AsiaJapan weighs taxing real estate rental operators living overseas— 日经 Nikkei AsiaJapan's foreign caregivers face exam hurdle as grace period ends— 日经 Nikkei AsiaThai highland tribe coffee brews following at home and in Tokyo— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei AsiaVietnam solar success prompts rethink of power pricing— 日经 Nikkei AsiaGlobal legal body opens Hong Kong office, boosts city's law hub push— 日经 Nikkei AsiaYen bond offerings hit record $16bn as AI funding race reaches Japan— 日经 Nikkei AsiaJapan weighs taxing real estate rental operators living overseas— 日经 Nikkei AsiaJapan's foreign caregivers face exam hurdle as grace period ends— 日经 Nikkei AsiaThai highland tribe coffee brews following at home and in Tokyo— 日经 Nikkei AsiaEU steps up subsea cable buildout to Japan and South Korea— 日经 Nikkei AsiaJapan's Don Quijote drops refund fees for tourists to boost spending— 日经 Nikkei AsiaVietnam solar success prompts rethink of power pricing— 日经 Nikkei AsiaGlobal legal body opens Hong Kong office, boosts city's law hub push— 日经 Nikkei Asia

Milestone cancer vaccine success leaves hard questions unanswered

출처 Science 科学7일 전
내용 요약

mRNA vaccine from Merck and Moderna slashes risk of melanoma’s return, but why remains unclear

본 사이트는 제목과 요약 색인만 제공하며, 전체 내용과 저작권은 모두 원 발행처에 있습니다. 원문 링크를 클릭하여 읽어 주세요.

원문 보기
소속 채널
과학
소속 지역
아메리카
원문 언어
English
항목 번호
science-dddec3cf

Comments 0 comments

No comments yet. Be the first.

Milestone cancer vaccine success leaves hard questions unanswered · 환우통감